The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

LAB Insider Trading (Standard BioTools)

Insider Ownership Percentage: 51.60%
Insider Buying (Last 12 Months): $1,140,611.82
Insider Selling (Last 12 Months): $0.00

Standard BioTools Insider Trading History Chart

This chart shows the insider buying and selling history at Standard BioTools by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Standard BioTools Share Price & Price History

Current Price: $1.76
Price Change: Price Increase of +0.02 (1.15%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for LAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

Standard BioTools Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2022Caligan Partners LpMajor ShareholderBuy46,009$1.74$80,055.6611,189,663View SEC Filing Icon  
8/1/2022Caligan Partners LpMajor ShareholderBuy210,200$1.48$311,096.0010,871,036View SEC Filing Icon  
7/29/2022Caligan Partners LpMajor ShareholderBuy137,648$1.42$195,460.1610,660,836View SEC Filing Icon  
6/13/2022Caligan Partners LpMajor ShareholderBuy100,000$1.70$170,000.0010,523,188View SEC Filing Icon  
6/2/2022Caligan Partners LpMajor ShareholderBuy200,000$1.92$384,000.0010,173,188View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Standard BioTools (NASDAQ:LAB)

Standard BioTools logo
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Read More on Standard BioTools

Today's Range

Now: $1.76
Low: $1.66
High: $1.77

50 Day Range

MA: $1.69
Low: $1.33
High: $2.07

52 Week Range

Now: $1.76
Low: $1.28
High: $7.31

Volume

897,170 shs

Average Volume

568,011 shs

Market Capitalization

$138.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Standard BioTools?

Standard BioTools' top insider shareholders include:
  1. Caligan Partners Lp (Major Shareholder)
Learn More about top insider investors at Standard BioTools.
Apple’s Next “Star Product” Could Replace The iPhone?
Apple's next "star product" could be its most profitable yet & may dominate a fast-growing new industry that Morgan Stanley projects will be worth a stunning $10 trillion!

The new “profit machine” could hand early investors a $190,717 payday.

How can you lock in your shot to 20X your money? 

See Here.
>>>